Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19
暂无分享,去创建一个
J. Lexchin | P. Doshi | J. Graham | K. Fierlbeck | M. Herder | Sterling Edmonds | Andrea MacGregor | A. Doll | Ipek Eren Vural